Every 8-K that The Vita Coco Company, Inc. (COCO) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow COCO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full COCO filings page.
The Vita Coco Company reported strong results for the quarter ended June 30, 2026. Net sales were $216.2 million, up 28% from $168.8 million, driven by case-equivalent volume growth in Vita Coco Coconut Water and Private Label plus higher net pricing. Gross profit rose to $105.3 million and consolidated gross margin improved to 48.7% of net sales from 36.3%, helped by tariff refunds and lower freight and finished goods costs.
Net income was $49.5 million, or $0.82 per diluted share, compared with $22.9 million, or $0.38 per diluted share, a year earlier. Non-GAAP Adjusted EBITDA was $67.2 million, more than double the prior-year $29.2 million. Year-to-date net sales were $395.9 million and net income $79.9 million.
The company ended June 30, 2026 with $278.6 million in cash and cash equivalents and no debt$44 million of common stock under its buyback program and, with a new $40 million authorization approved July 21, 2026, has total authorized repurchases of $105 million. Full-year 2026 guidance was raised to net sales of $790–$805 million, gross margin of about 40%, and Adjusted EBITDA of $154–$161 million. Vita Coco also disclosed the acquisition of Copra, Inc., a producer of super-premium Thai Nam Hom coconut water.
The Vita Coco Company, Inc. completed the acquisition of Copra Inc., a producer of super-premium Thai Nam Hom coconut water, on July 22, 2026. Closing consideration totaled $175 million, composed of 467,071 Vita Coco shares and $140,000,210.59 in cash, with Copra shareholders also eligible for an additional earnout.
The aggregate earnout ranges from $45 million to $100 million based on Copra’s 2028 gross profit and will be paid in 2029 in cash, Vita Coco stock, or both, with at least 24% in cash. Copra expects full-year 2026 net sales above $100 million and has delivered a 48% net sales CAGR over the past three years.
Stock consideration was issued in a private placement, with Copra holders capped at 19.99% of Vita Coco’s pre-deal shares absent stockholder approval and granted registration rights for resale. Vita Coco expects the transaction to be accretive to its Adjusted EBITDA margins while maintaining mid-teens branded net sales growth and high-teens Adjusted EBITDA margin targets.
The Vita Coco Company, Inc. reported the results of its annual stockholder meeting held on June 3, 2026. Stockholders owning 50,426,796 shares of common stock were present or represented by proxy, representing approximately 88.49 percent of the voting power as of the April 7, 2026 record date.
Three Class II directors — Shelley Broader, Michael Kirban and Kenneth Sadowsky — were elected for terms expiring at the 2029 annual meeting. Each received substantially more votes "for" than "withheld," with several million broker non-votes recorded on the director proposals.
Stockholders also ratified the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 50,014,018 votes for, 401,208 against and 11,570 abstentions. In addition, they approved the advisory vote on executive compensation with 44,532,948 votes for, 2,168,378 against, 31,044 abstentions and 3,694,426 broker non-votes.
The Vita Coco Company reported a strong first quarter of 2026, combining rapid growth with higher profitability and a guidance increase for the full year. Net sales reached $179.8 million, up 37% from $130.9 million, driven by 42% growth in Vita Coco Coconut Water and double‑digit gains in private label and other products. Gross profit rose to $71.8 million, lifting gross margin to about 40% from 36.7% as higher pricing and lower ocean freight more than offset higher inventory and logistics costs.
Net income increased to $30.5 million, or $0.50 per diluted share, compared with $0.31, while non‑GAAP Adjusted EBITDA grew to $38.7 million from $22.5 million. The company ended the quarter with $201.9 million in cash and no debt, after repurchasing $12 million of stock in the quarter and $20 million year‑to‑date through April 28, leaving $21 million authorized under its buyback program. For 2026, Vita Coco now expects net sales between $720 million and $735 million and Adjusted EBITDA between $132 million and $138 million, both higher than its prior outlook, supported by continued brand strength and improved private label trends.
The Vita Coco Company, Inc. filed an amended current report to update the responsibilities of recently appointed director Shelley Broader. She joined the Board on January 7, 2026, and on April 17, 2026, the Board appointed her to the Audit Committee and the Compensation Committee.
Her committee service will be effective June 3, 2026, following the Company’s 2026 Annual Meeting of Stockholders. The filing is signed by Chief Executive Officer Martin Roper on behalf of the Company.
The Vita Coco Company, Inc. announced that board member John Leahy will retire from its Board of Directors and will not stand for reelection at the Company’s 2026 Annual Meeting of Stockholders on June 3, 2026. He has served on the Board since 2019 and is a member of both the Audit Committee and the Compensation Committee, continuing in these roles until his term ends at the meeting. The Company states that Mr. Leahy’s decision is solely for personal reasons and not due to any disagreement over operations, policies, or practices. After his retirement, the Board’s size will decrease from ten members to nine.
The Vita Coco Company reported strong fourth quarter and full year 2025 results, with full year net sales of $610 million, up 18%, driven by 26% growth in Vita Coco Coconut Water. Full year net income rose to $71 million from $56 million, and diluted EPS increased to $1.19 from $0.94.
Non-GAAP Adjusted EBITDA grew to $98 million from $84 million, supported by higher pricing and volume, despite tariff and cost pressures. The company ended 2025 with no debt, cash and cash equivalents of $197 million, and executed $11.3 million of share repurchases, leaving $40.9 million authorized.
For fiscal 2026, Vita Coco expects net sales between $680 million and $700 million, gross margin of about 38%, and Adjusted EBITDA between $122 million and $128 million, reflecting continued growth in Vita Coco Coconut Water and improving Private Label trends.
The Vita Coco Company reported board and leadership changes. On January 7, 2026, the Board of Directors increased its size from nine to ten members and appointed Shelley Broader as a Class II director, serving until the end of Class II’s term at the next annual meeting of stockholders and until a successor is elected and qualified. She will receive the standard non-employee director compensation and is expected to be named to one or more board committees later.
The company stated that Ms. Broader has no arrangements related to her appointment and no material related-party transactions requiring disclosure. On January 7, 2026, the Board also appointed Charles van Es as Chief Commercial Officer, effective January 1, 2026, to lead global commercial strategy and market development while continuing to oversee the U.S. market, with no changes to his compensation.
The Vita Coco Company, Inc. filed a current report to let investors know it has issued a press release about tariff relief affecting the business. The company used this filing under Regulation FD, which is designed to share important information with all investors at the same time. The press release, dated November 17, 2025, is attached as an exhibit and incorporated by reference. The disclosure is being furnished rather than filed, meaning it does not carry certain legal liabilities that formal financial statements do.
The Vita Coco Company, Inc. (COCO) furnished an update on its operations by announcing financial results for the three months ended September 30, 2025. The results were disclosed through a press release furnished as Exhibit 99.1 to a Form 8-K under Item 2.02. The company noted that the information is being furnished and not deemed filed for purposes of Section 18 of the Exchange Act.
On 30 July 2025, The Vita Coco Company, Inc. (COCO) filed a Form 8-K announcing that it has furnished (not filed) a press release containing financial results for the quarter ended 30 June 2025. The actual earnings figures are not included in the filing; they are contained in Exhibit 99.1. Accordingly, today’s 8-K serves only to formally disclose the release and provide XBRL cover-page data. No guidance revisions, strategic actions, or other material transactions are described.